After five years of unprecedented momentum, the ADC field now finds itself at an interesting inflection point. With more programs in development and greater industry prioritization than ever before, ...

Antibody-drug conjugates are receiving unrivaled attention across the biopharma sector. Fueled by Enhertu’s tumor-agnostic accelerated approval, practice changing combination results from Seagen and ...

You may have noticed an officer standing just behind the President of India at official events, state visits, or ceremonial functions. That officer holds a very important role as an Aide-de-Camp (ADC) ...

Former Vice President Atiku Abubakar, 2023 Labour Party presidential candidate Peter Obi, former Senate President David Mark and other coalition leaders have officially adopted the African Democratic ...

In a significant shift in Nigeria’s political landscape, the Atiku Abubakar-led opposition coalition has formally adopted the African Democratic Congress (ADC) as its platform to challenge President ...

After flexing its antibody-drug conjugate bona fides at last year’s American Society of Clinical Oncology (ASCO) conference, AbbVie is advancing its solid tumor ambitions with a new FDA green light.

Antibody-drug conjugates (ADCs) are a growing class of biotherapeutics that have transformed targeted therapy, especially in oncology. By making use of monoclonal antibodies’ specificity to deliver ...

Merck & Co. has shown off data on its ROR1-directed antibody-drug conjugate (ADC), trumpeting a 100% complete response rate but also reporting safety signals that informed the decision to take the low ...

ADC Therapeutics has stopped development of lead solid tumor candidate ADCT-601. The biotech axed the AXL-directed antibody-drug conjugate (ADC) after failing to show a favorable benefit-risk profile ...

Tour de Bodock bike ride director Bob McGee said that registration for the Saturday, September 14, event is currently ahead of this time last year, and that 2023 event attracted 308 registrants from ...

BUENA PARK, Calif.--(BUSINESS WIRE)--ADC Aerospace (“ADC” or the “Company”), a leading manufacturer of complex, highly-engineered turnkey die-cast parts used in critical applications in the aerospace, ...

The sizzling antibody-drug conjugate (ADC) field is at the center of another major life sciences deal. This time, AbbVie is shelling out $10.1 billion in cash to acquire ImmunoGen, maker of the ...